Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells

The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia

(2011) Teresa Palomero et al.   CELL CYCLE

A new target for proteasome inhibitors: FoxM1

(2010) Andrei L Gartel   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

TW-37, a Small-Molecule Inhibitor of Bcl-2, Inhibits Cell Growth and Induces Apoptosis in Pancreatic Cancer: Involvement of Notch-1 Signaling Pathway

(2009) Z. Wang et al.   CANCER RESEARCH

Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression

(2009) Q. Li et al.   CANCER RESEARCH

Treatment of prostate cancer in unfit senior adult patients

(2009) Cristina Falci et al.   CANCER TREATMENT REVIEWS

Forkhead box M1 transcription factor: A novel target for cancer therapy

(2009) Zhiwei Wang et al.   CANCER TREATMENT REVIEWS

The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism

(2009) Raphael Kopan et al.   CELL

Targeted Knockdown of Notch1 Inhibits Invasion of Human Prostate Cancer Cells Concomitant with Inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen Activator

(2009) B. Bin Hafeez et al.   CLINICAL CANCER RESEARCH

Efficacy and Safety of the Combination of Docetaxel (Taxotere®) with Targeted Therapies in the Treatment of Solid Malignancies

(2009) Vincenzo Chiuri et al.   CURRENT DRUG TARGETS

FoxM1, a critical regulator of oxidative stress during oncogenesis

(2009) Hyun Jung Park et al.   EMBO JOURNAL

Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer

(2008) Nuran Bektas et al.   BMC CANCER

Multi-targeted therapy of cancer by genistein

(2008) Sanjeev Banerjee et al.   CANCER LETTERS

Notch Signaling: A Potential Therapeutic Target in Prostate Cancer

(2008) M. Villaronga et al.   CURRENT CANCER DRUG TARGETS

The Notch pathway in prostate development and cancer

(2008) Kevin G. Leong et al.   DIFFERENTIATION

FoxM1 inhibitors as potential anticancer drugs

(2008) Andrei L Gartel   EXPERT OPINION ON THERAPEUTIC TARGETS

Rational targeting of Notch signaling in cancer

(2008) P Rizzo et al.   ONCOGENE